These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1055 related articles for article (PubMed ID: 7755915)
1. Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre. Aisu T; Raviglione MC; van Praag E; Eriki P; Narain JP; Barugahare L; Tembo G; McFarland D; Engwau FA AIDS; 1995 Mar; 9(3):267-73. PubMed ID: 7755915 [TBL] [Abstract][Full Text] [Related]
2. Cost-utility of tuberculosis prevention among HIV-infected adults in Kampala, Uganda. Shrestha RK; Mugisha B; Bunnell R; Mermin J; Odeke R; Madra P; Hitimana-Lukanika C; Adatu-Engwau F; Blandford JM Int J Tuberc Lung Dis; 2007 Jul; 11(7):747-54. PubMed ID: 17609049 [TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of including tuberculin skin testing in an IPT program for HIV-infected persons in Uganda. Shrestha RK; Mugisha B; Bunnell R; Mermin J; Hitimana-Lukanika C; Odeke R; Madra P; Adatu F; Blandford JM Int J Tuberc Lung Dis; 2006 Jun; 10(6):656-62. PubMed ID: 16776453 [TBL] [Abstract][Full Text] [Related]
4. Operational assessment of isoniazid prophylaxis in a community AIDS service organisation in Uganda. Lugada ES; Watera C; Nakiyingi J; Elliott A; Brink A; Nanyunja M; French N; Antivelink L; Gilks C; Whitworth J Int J Tuberc Lung Dis; 2002 Apr; 6(4):326-31. PubMed ID: 11936742 [TBL] [Abstract][Full Text] [Related]
5. Tuberculosis case finding and preventive therapy in an HIV voluntary counseling and testing center in Uganda. Mugisha B; Bock N; Mermin J; Odeke RM; Miller B; Adatu-Engwau F; Granich R; Bunnell R Int J Tuberc Lung Dis; 2006 Jul; 10(7):761-7. PubMed ID: 16848338 [TBL] [Abstract][Full Text] [Related]
6. The cost of intensified case finding and isoniazid preventive therapy for HIV-infected patients in Battambang, Cambodia. Sutton BS; Arias MS; Chheng P; Eang MT; Kimerling ME Int J Tuberc Lung Dis; 2009 Jun; 13(6):713-8. PubMed ID: 19460246 [TBL] [Abstract][Full Text] [Related]
7. Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease. Graham NM; Galai N; Nelson KE; Astemborski J; Bonds M; Rizzo RT; Sheeley L; Vlahov D Arch Intern Med; 1996 Apr; 156(8):889-94. PubMed ID: 8774208 [TBL] [Abstract][Full Text] [Related]
9. Loss to follow up from isoniazid preventive therapy among adults attending HIV voluntary counseling and testing sites in Uganda. Namuwenge PM; Mukonzo JK; Kiwanuka N; Wanyenze R; Byaruhanga R; Bissell K; Zachariah R Trans R Soc Trop Med Hyg; 2012 Feb; 106(2):84-9. PubMed ID: 22154974 [TBL] [Abstract][Full Text] [Related]
10. Isoniazid preventive therapy in human immunodeficiency virus-infected persons. Long-term effect on development of tuberculosis and survival. Moreno S; Miralles P; Diaz MD; Baraia J; Padilla B; Berenguer J; Alberdi JC Arch Intern Med; 1997 Aug 11-25; 157(15):1729-34. PubMed ID: 9250234 [TBL] [Abstract][Full Text] [Related]
11. Completion of isoniazid preventive therapy among HIV-infected patients in Tanzania. Munseri PJ; Talbot EA; Mtei L; Fordham von Reyn C Int J Tuberc Lung Dis; 2008 Sep; 12(9):1037-41. PubMed ID: 18713501 [TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of directly observed chemoprophylaxis of tuberculosis among drug users at high risk for tuberculosis. Gourevitch MN; Alcabes P; Wasserman WC; Arno PS Int J Tuberc Lung Dis; 1998 Jul; 2(7):531-40. PubMed ID: 9661818 [TBL] [Abstract][Full Text] [Related]
13. Instability of tuberculin and Candida skin test reactivity in HIV-infected Ugandans. The Uganda-Case Western Reserve University Research Collaboration. Johnson JL; Nyole S; Okwera A; Whalen CC; Nsubuga P; Pekovic V; Huebner R; Wallis RS; Mugyenyi PN; Mugerwa RD; Ellner JJ Am J Respir Crit Care Med; 1998 Dec; 158(6):1790-6. PubMed ID: 9847269 [TBL] [Abstract][Full Text] [Related]
14. Influence of the human immunodeficiency virus in the incidence of tuberculosis in a cohort of intravenous drug users: effectiveness of anti-tuberculosis chemoprophylaxis. Jansà JM; Serrano J; Caylà JA; Vidal R; Ocaña I; Español T Int J Tuberc Lung Dis; 1998 Feb; 2(2):140-6. PubMed ID: 9580481 [TBL] [Abstract][Full Text] [Related]
15. [Primary chemoprevention of tuberculosis in HIV-infected patients in non-industrialized countries]. Anglaret X; Dabis F; Batungwanayo J; Perronne C; Taelman H; Bonard D; Sylla-Koko F; Leroy V; Van de Perre P; Vildé JL; Salamon R Sante; 1997; 7(2):89-94. PubMed ID: 9273126 [TBL] [Abstract][Full Text] [Related]
16. Modelling the economic benefits of tuberculosis preventive therapy for people with HIV: the example of Zambia. Foster S; Godfrey-Faussett P; Porter J AIDS; 1997 Jun; 11(7):919-25. PubMed ID: 9189218 [TBL] [Abstract][Full Text] [Related]
17. Tuberculosis vaccination versus isoniazid preventive therapy: a decision analysis to determine the preferred strategy of tuberculosis prevention in HIV-infected adults in the developing world. Sterling TR; Brehm WT; Moore RD; Chaisson RE Int J Tuberc Lung Dis; 1999 Mar; 3(3):248-54. PubMed ID: 10094327 [TBL] [Abstract][Full Text] [Related]
18. Chemoprophylaxis for tuberculosis in HIV-infected individuals in sub-Saharan Africa. Nuwaha F East Afr Med J; 1998 Sep; 75(9):520-7. PubMed ID: 10493054 [TBL] [Abstract][Full Text] [Related]
19. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
20. Completion of isoniazid preventive therapy and survival in HIV-infected, TST-positive adults in Tanzania. Kabali C; von Reyn CF; Brooks DR; Waddell R; Mtei L; Bakari M; Matee M; Pallangyo K; Arbeit RD; Horsburgh CR Int J Tuberc Lung Dis; 2011 Nov; 15(11):1515-21, i. PubMed ID: 22008766 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]